Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 137, Issue 8, Pages 2029-2039
Publisher
Wiley
Online
2015-04-22
DOI
10.1002/ijc.29574
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis
- (2015) Sudhakar V. Nuti et al. Oncotarget
- Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles
- (2015) Xunhao Xiong et al. Oncotarget
- Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925
- (2014) X Yang et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Better Therapeutic Trials in Ovarian Cancer
- (2014) M. A. Bookman et al. JNCI-Journal of the National Cancer Institute
- Integrin β3 links therapy resistance and cancer stem cell properties
- (2014) Nagarajan Kannan et al. NATURE CELL BIOLOGY
- Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug
- (2013) V. Shah et al. CLINICAL CANCER RESEARCH
- New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
- (2013) S. Banerjee et al. CLINICAL CANCER RESEARCH
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies
- (2012) S. Murray et al. CANCER TREATMENT REVIEWS
- Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation
- (2012) Z. Duan et al. CLINICAL CANCER RESEARCH
- Synthesis and Evaluation of (2-(4-Methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) Isomers To Reverse Multidrug Resistance in Cancer
- (2012) Zhenfeng Duan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO)
- (2011) A. Lortholary et al. ANNALS OF ONCOLOGY
- Src family kinases and paclitaxel sensitivity
- (2011) Xiao-Feng Le et al. CANCER BIOLOGY & THERAPY
- The controversial role of ABC transporters in clinical oncology
- (2011) Akina Tamaki et al. Essays in Biochemistry
- miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo
- (2011) A Holleman et al. ONCOGENE
- Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells
- (2009) K. Simonin et al. MOLECULAR CANCER THERAPEUTICS
- NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance
- (2009) Zhenfeng Duan et al. PLoS One
- Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines
- (2008) Zhenfeng Duan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer
- (2008) Catherine Lhommé et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant
- (2008) Amit K. Sharma et al. JOURNAL OF CONTROLLED RELEASE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started